LIFECORE BIOMEDICAL, INC. DE - COM (LFCR)

Historical Portfolio Holders from Q1 2014 to Q2 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
18.6M
Holdings value Q2 2024
$95.4M
Value change Q2 2024
-$6.03M
Grand Portfolio weight change Q2 2024
0%
Number of holders
73
Number of buys Q2 2024
40
Number of sells Q2 2024
-40
Average buys Q2 2024 %
+0%
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q2 18.6M $95.4M -$6.03M $5.13 74
2024 Q1 21.5M $114M +$1.28M $5.31 75
2023 Q4 21.2M $131M +$7.75M $6.19 77
2023 Q3 17.6M $132M -$4.24M $7.55 68
2023 Q2 18M $174M -$23.6M $9.67 76
2023 Q1 21.6M $81.7M -$19.2M $3.78 80
2022 Q4 24.7M $160M -$421K $6.48 91
2022 Q3 24.7M $220M -$5.08M $8.89 83
2022 Q2 25.3M $252M -$4.81M $9.97 86
2022 Q1 23.5M $272M -$4.45M $11.58 95
2021 Q4 25.9M $287M +$3.1M $11.10 96
2021 Q3 25.5M $235M +$11.3M $9.22 92
2021 Q2 25.6M $288M -$5.84M $11.25 95
2021 Q1 26M $275M -$6.2M $10.60 92
2020 Q4 26.5M $288M -$1.87M $10.85 95
2020 Q3 27.3M $265M +$8.4M $9.72 95
2020 Q2 26.8M $213M -$2.39M $7.96 91
2020 Q1 27.1M $235M -$2.45M $8.69 87
2019 Q4 27.1M $306M +$279K $11.31 92
2019 Q3 26.5M $288M -$10.6M $10.87 102
2019 Q2 27.5M $258M +$10M $9.37 98
2019 Q1 26.3M $323M +$5.33M $12.28 90
2018 Q4 25.9M $306M -$563K $11.84 88
2018 Q3 25.7M $367M -$2.82M $14.40 89
2018 Q2 25.1M $374M -$6.66M $14.90 89
2018 Q1 26.3M $343M +$5.9M $13.05 88
2017 Q4 25.8M $325M -$305K $12.60 90
2017 Q3 25.8M $334M +$6.06M $12.95 94
2017 Q2 25.3M $376M +$3.25M $14.85 94
2017 Q1 25.1M $301M +$27.1M $12.00 83
2016 Q4 24.7M $340M -$4.66M $13.80 92
2016 Q3 25M $336M -$7.68M $13.41 90
2016 Q2 25.5M $275M +$12.9M $10.76 90
2016 Q1 25M $263M +$7.1M $10.50 90
2015 Q4 24.4M $289M +$6.28M $11.83 106
2015 Q3 23.8M $277M -$6.27M $11.67 110
2015 Q2 24.2M $350M -$429K $14.43 107
2015 Q1 24M $335M -$387K $13.95 99
2014 Q4 24.1M $333M -$1.19M $13.81 106
2014 Q3 24.2M $295M +$2.84M $12.25 105
2014 Q2 23.9M $298M +$4.41M $12.49 99
2014 Q1 23.7M $264M -$9.5M $11.16 97